Related Experiment Video
Updated: Aug 7, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Summary
Improved Hodgkin
Area of Science:
- Oncology
- Hematology
- Clinical Medicine
Background:
- Hodgkin's disease treatment has evolved significantly over decades.
- Historical survival rates for Hodgkin's disease were considerably lower.
- Understanding treatment efficacy requires analyzing patient outcomes over time.
Purpose of the Study:
- To evaluate the impact of evolving treatment strategies on Hodgkin's disease patient survival.
- To compare survival rates from different treatment eras.
- To identify factors contributing to improved outcomes in recent patient cohorts.
Main Methods:
- Analysis of Hodgkin's disease patients under 66 treated between 1965-1973 at Massachusetts General Hospital.
- Patients divided into early (1965-1968) and late (1969-1973) treatment groups.
- Actuarial survival analysis (Berkson and Gage) compared to a historical series (1948-1964).
Main Results:
- Five-year survival for all stages of Hodgkin's disease improved dramatically: 87% (1969-1973) vs. 65% (1965-1968) vs. 34% (1948-1964).
- Improved management of advanced stages (III and IV) attributed to surgical staging and combination chemotherapy.
- Low recurrence in Stage IA/IIA patients after irradiation and laparotomy; higher relapse in symptomatic Stages IB/IIB.
Conclusions:
- Modern treatment protocols have significantly enhanced Hodgkin's disease survival rates.
- Surgical staging and combination chemotherapy are key factors in managing advanced disease.
- High relapse rates in certain stages necessitate caution in predicting long-term cure rates.
